블로그

• [FDA, 200616] 키트루다, 고형암 환자 대상 허가 the Food and Drug Administration granted accelerated approval to pembrolizumab (KEYTRUDA, Merck & Co Today, the FDA a....... blog.naver.com · 2020.06.30